×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
西安交通大学 [175]
内容类型
期刊论文 [168]
会议论文 [7]
发表日期
2019 [6]
2018 [27]
2017 [32]
2016 [35]
2015 [25]
2014 [10]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共175条,第1-10条
帮助
限定条件
专题:西安交通大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis
期刊论文
MOLECULES AND CELLS, 2019, 卷号: 42, 页码: 270-283
作者:
Yang, Tian
;
Li, Hong
;
Chen, Tianjun
;
Ren, Hui
;
Shi, Puyu
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/11/19
Animal model
P120-catenin
LncRNA MALAT1
non-small cell lung cancer
MiR-197-3p
Chemo-sensitivity
Cell viability
SUMO1 promotes the proliferation and invasion of non-small cell lung cancer cells by regulating NF-κB
期刊论文
Thoracic Cancer, 2019, 卷号: 10, 页码: 33-40
作者:
Ke, Changkang
;
Zhu, Kai
;
Sun, Ying
;
Ni, Yunfeng
;
Zhang, Zhipei
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/11/19
NF-&kappa
B
NSCLC
SUMO1
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.
期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:
Si Xiaoyan
;
Zhang Li
;
Wang Hanping
;
Zhang Xiaotong
;
Wang Mengzhao
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/11/19
non-small cell lung cancer
multi-target tyrosine kinase inhibitor
Adverse event
anlotinib
Cetuximab and Doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparticles as novel targeted nanocarriers for non-small cell lung cancer
期刊论文
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2019, 卷号: 481, 页码: 122-128
作者:
Zhang, Qinlu
;
Liu, Qian
;
Du, Menghan
;
Vermorken, Alphons
;
Cui, Yali
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2019/11/19
Drug targeting
Cetuximab
Doxorubicin
Non-small cell lung cancer
Nanoparticles
Epidermal growth factor receptor
Erlotinib versus gemcitabine/cisplatin in Chinese patients with EGFR mutation-positive advanced non-small-cell lung cancer: Crossover extension and post-hoc analysis of the ENSURE study
期刊论文
LUNG CANCER, 2019, 卷号: 130, 页码: 18-24
作者:
Wu, Yi-Long
;
Zhou, Caicun
;
Lu, Shun
;
Qin, Shukui
;
Pan, Hongming
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2019/11/19
Chemotherapy
EGFR
Asian
Non small cell lung cancer
Erlotinib
Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients.
期刊论文
Aging, 2019, 卷号: 11, 页码: 467-479
作者:
Miao Runchen
;
Ge Cuiyun
;
Zhang Xing
;
He Yang
;
Ma Xiaohua
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2019/11/19
long non-coding RNA
prognosis
NSCLC
the elderly
Ornithine aminotransferase promoted the proliferation and metastasis of non-small cell lung cancer via upregulation of miR-21.
期刊论文
Journal of cellular physiology, 2018
作者:
Liu Yanfeng
;
Wu Lei
;
Li Kai
;
Liu Fengrui
;
Wang Li
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/11/19
miR-21
proliferation
ornithine aminotransferase
GSK-3&beta
non-small cell lung cancer
invasion and migration
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study
会议论文
作者:
Zhong, W-Z.
;
Wu, Y-L.
;
Chen, K-N.
;
Chen, C.
;
Gu, C-D.
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/11/19
Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer.
期刊论文
Anti-cancer agents in medicinal chemistry, 2018, 卷号: 18, 页码: 1680-1687
作者:
Hu Tinghua
;
Yu Shuo
;
Cheng Chuantao
;
Wang Jing
;
Wang Jia
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/11/19
clinicopathological
prognostic
biomarker
Beclin1
non-small cell lung cancer
Nrf2
Tissue or blood: which is more suitable for detection of EGFR mutations in non-small cell lung cancer?
期刊论文
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 卷号: 33, 页码: 40-48
作者:
Rong Biaoxue
;
Yang Shuanying
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/11/19
EGFR mutations
Meta-analysis
Tissue
Blood
Non-small cell lung cancer
NSCLC
©版权所有 ©2017 CSpace - Powered by
CSpace